Status:
UNKNOWN
Retrospective Study of Effect of Adjuvant Chemoradiation of Gastric Carcinoma on Local Control and Survival
Lead Sponsor:
Assiut University
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-70 years
Brief Summary
Gastric cancer is the sixth most common cancer and the third most common cause of cancer-related death in the world. The American Cancer Society estimates that about 26,560 cases of stomach cancer (1...
Detailed Description
Gastric cancer is the sixth most common cancer and the third most common cause of cancer-related death in the world. The American Cancer Society estimates that about 26,560 cases of stomach cancer (1...
Eligibility Criteria
Inclusion
- Age between 18 to 70 years.
- The World Health Organization Performance score 0-2.
- Haemoglobin at least 10g/dl.
- White blood cells at least 3000/mm3.
- Platelets count at least 100000/mm3.
- Bilirubin concentration no more than 25% higher than upper limit of normal .
- Liver enzymes no greater than 2.5 times upper limit of normal.
- Alkaline phosphatase no greater than 2 times upper limit of normal.
- Creatinine concentration no more than 25% higher than the upper limit of normal .
Exclusion
- Second malignancy.
- Prior abdominal irradiation.
- Pregnant or nursing female.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05287672
Start Date
June 1 2022
End Date
December 1 2023
Last Update
March 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.